Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Industry opposes genomic legislation.

Chahine K.

Nat Biotechnol. 2002 May;20(5):419. No abstract available.

PMID:
11981541
2.

Industry opposes genomic legislation.

Merz JF, Leonard DG, Kriss AG, Cho MK.

Nat Biotechnol. 2002 Jul;20(7):657; author reply 657. No abstract available.

PMID:
12089543
3.

When the human genome project and state street collide.

Locke SD, Kalow DA.

Nat Biotechnol. 2000 Sep;18(9):1009-10. No abstract available.

PMID:
10973226
4.

The US biotechnology industry: an analysis of trends.

Dibner MD.

Aust J Biotechnol. 1988 Sep;2(2):129-32. No abstract available.

PMID:
2485326
5.

The effect of intellectual property on the biotechnology industry.

Davis JH, Wales MM.

Adv Genet. 2003;50:427-39; discussion 507-10. No abstract available.

PMID:
14714703
6.

Into the 21st century. Biotechnology and the pharmaceutical industry in the next ten years.

Drews J.

Biotechnology (N Y). 1993 Mar;11(3):S16-20. No abstract available.

PMID:
7763432
7.

Politicians seek to block human-gene patents in Europe.

Abbott A, Hellerer U.

Nature. 2000 Apr 20;404(6780):802. No abstract available.

PMID:
10819663
8.

Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.

Spranger TM.

IIC Int Rev Ind Prop Copyr Law. 2000 Jun;31(4):373-80. No abstract available.

PMID:
12956125
9.

Commentary on the panel presentations.

Newman P.

Adv Genet. 2003;50:355-9; discussion 507-10. No abstract available.

PMID:
14714699
10.

The gene patenting controversy: a convergence of law, economic interests, and ethics.

Kevles DJ, Berkowitz A.

Brooklyn Law Rev. 2001 Fall;67(1):233-48. No abstract available.

PMID:
12645549
11.

Pharmaceutical patent life-cycle management after KSR v. Teleflex.

Furrow ME.

Food Drug Law J. 2008;63(1):275-320. No abstract available.

PMID:
18561462
12.

Patenting pieces of people.

[No authors listed]

Nat Biotechnol. 2003 Apr;21(4):341. No abstract available.

PMID:
12665804
13.

Whistling in the wind: patents on genetic research are a reality. It's time to reframe the debate.

Caulfield TA, Gold ER.

Forum Appl Res Public Policy. 2000 Spring;15(1):75-9. No abstract available.

PMID:
17333589
14.

Bioprospecting, genetic patenting and indigenous populations: challenges under a restructured information commons.

Faye DJ.

J World Intellect Prop. 2004 May;7(3):401-28. No abstract available.

PMID:
16755699
15.

Finding common cause in the patent debate.

Gold ER.

Nat Biotechnol. 2000 Nov;18(11):1217-8. No abstract available.

PMID:
11062446
16.

Patent drop reveals pressures on industry.

Lawrence S.

Nat Biotechnol. 2004 Aug;22(8):930-1. No abstract available. Erratum in: Nat Biotechnol. 2004 Dec;22(12):1589.

PMID:
15286630
17.

Biotech as Bush bows out.

Lorenzo A.

Nat Biotechnol. 2008 Jan;26(1):15-8. doi: 10.1038/nbt0108-15. No abstract available.

PMID:
18183006
18.

Patenting race.

Kahn J.

Nat Biotechnol. 2006 Nov;24(11):1349-51.

PMID:
17093476
19.

Recent patent applications in tissue engineering.

[No authors listed]

Nat Biotechnol. 2006 Sep;24(9):1095. No abstract available.

PMID:
16964216
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk